The world’s preeminent accolade for life science research and innovation will return to the Taj Palace in New Delhi on March 19, 2026, for its highly anticipated next edition.

The Prix Galien India Awards committee include 14 esteemed leaders in the life sciences in India. The committee is a neutral body and follows the Prix Galien India Charter in selecting the best of the best in biopharmaceutical research and development. The selection committee will be supported by two sub-comittees that will short list finalists to the competition.

“As we move forward, it is crucial that we continue to foster an ecosystem that encourages innovation and collaboration. The future of healthcare depends on our ability to work together towards transformative solutions,” said Dr. Renu Swarup, Former Modi Prix Galien India Committee Chair.

JURY MEMBERS:

Dr Digamber Behra, Padma Shri President, National Academy of Medical Sciences

Dr Subi Chaturvedi, SVP & Chief Corporate Affairs & Public Policy Officer, InMobi

Dr Alok Dhawan, Centre for Biomedical Research, Lucknow

Shri Anil Khanna, Sr. Vice President, GM Modi Science Foundation, New Delhi

Dr Indranil Manna, President, Indian National Academy of Engineering

Dr Narinder Kr. Mehra, Vice-President, International Affairs

Prof Ashwani Nangia, Department of Chemistry, University of Hyderabad

Dr Prashant Parkash, Padma Shri Founding Partner, Accel India; Chairman, Karnataka’s Vision Group for Startups

Dr JD Patil, President, Indian National Academy of Engineering

Dr Padmaja Ruparel, President, Indian Angel Network & Managing Partner, IAN Fund

Dr Dipankar Das Sarma, Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore

Prof Anurag Sharma, IIT Delhi

Dr Sanjay Singh, Chief Executive Officer, Gennova Biopharmaceuticals Ltd., Pune

Dr Rohit Srivastava, IIT Mumbai

Dr Umesh Waghmare, President, Indian Academy of Science, Bangalore

SUB-COMMITTEE-I - BIOTECH PRODUCT / PRODUCT FOR ORPHAN / RARE DISEASES

Dr Anurag Agrawal, Former Director, Institute of Genomics and Integrative Biology (CSIR)

Dr Sudha Bhattacharya, The National Academy of Sciences of India

Prof Alok Dhawan, ICMR-Dr. A. S. Paintal Distinguished Scientist Chair, New Delhi; Former Director, CSIR-Indian Institute of Toxicology Research, Lucknow;
Former Director, Centre of BioMedical Research, Lucknow

Sonia Gandhi, GM, Biotechnology Industry Research Council

Dr Arbinda Mitra, Former Scientific Secretary, Office of the Principal Scientific Adviser to the Government of India

Dr Arvind Sahu, Director, Regional Centre for Biotechnology, Faridabad

Dr Shashi Bala Singh, Director, NIPER, Hyderabad

Prof Nikhil Tandon, AIIMS, New Delhi

Dr Anil Kumar Tripathi, Director, IISER Mohali

Dr Harikrishan Verma, Regional Research Laboratory (CSIR)

Prof Sudhanshu Vrati, Former Executive Director, Regional Centre for Biotechnology / ex-RCB Faridabad

SUB-COMMITTEE-II - MEDICAL TECHNOLOGY (INCLUDING DIAGNOSTIC TOOLS) / STARTUP / DIGITAL HEALTH SOLUTION / INCUBATOR-ACCELERATOR

Dr Subi Chaturvedi, SVP & Chief Corporate Affairs & Public Policy Officer, InMobi

Dr Gobardhan Das, Director, The Indian Institute of Science Education and Research, Bhopal

Dr Keshav Deo, CMD, Lifeactivus Pvt Ltd

Dr Debasisa Mohanty, Director, National Institute of Immunology

Dr Prashant Parkash, Padma Shri, Founding Partner, Accel India; Chairman, Karnataka’s Vision Group for Startups

Dr Padmaja Ruparel, President, Indian Angel Network & Managing Partner, IAN Fund

Dr Jitendra Sharma, AMTZ Campus, Visakhapatnam

Dr Rana P. Singh, Vice Chancellor, Gautam Buddha University, Noida

Dr Sanjeev Sinha, Head, Department of Medicine, AIIMS

Dr Umakant Soni, Co-founder of ARTPARK, India’s First AI Research Translation Park

Dr Rohit Srivastava, IIT, Bombay

Dr Mrutyunjay Suar, DG R&D and Innovation, KIIT University, Bhubaneswar

Highlights from the first edition
Message from the World Economic Forum